Unlike HGH, AOD 9604 has no growth-promoting effects, which makes it safer to use as part of a targeted therapy plan
In the Phase 3 obesity trial, rates were about 5%, 12%, and 13% at 4, 9, and 12 mg
PLoS ONE, 5(3), e9505
Add your clinical experience in the comments for community discussion
Its also the only vetted program offering a structured microdosing option lower-dose protocols designed for gentler titration, which matters for medication-sensitive patients
Add our AHK-Cuto any hair and skincare product (scalp serum, shampoo, cream, conditioners, or moisturizer) or make a customhair-loss formula